Vor Biopharma Stock Quote VOR - Stock Price, News, Charts, Message Board, Trades

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Vor Biopharma Inc (VOR) Quote

Vor Biopharma Inc (VOR)

0.8639

-0.0334

(-3.72%)

Closed November 15 4:00PM

Delayed by 15 minutes

0.8546

-0.0093

(-1.08%)

After Hours: 6:56PM

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Current Price

0.8546

Bid

0.8501

Ask

0.8998

Volume

385,040

0.84 Day's Range 0.93

0.6354 52 Week Range 3.1399

Market Cap

Previous Close

0.8973

Open

0.93

Last Trade

Last Trade Time

Financial Volume

$ 337,704

VWAP

0.877062

Average Volume (3m)

1,008,998

Shares Outstanding

68,398,826

Dividend Yield

-

PE Ratio

-0.50

Earnings Per Share (EPS)

-1.72

Revenue

-

Net Profit

-117.86M

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33. Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.vorbio.com

Headquarters

Wilmington, Delaware, USA

Founded

-

Vor Biopharma Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker VOR. The last closing price for Vor Biopharma was $0.90. Over the last year, Vor Biopharma shares have traded in a share price range of $ 0.6354 to $ 3.1399.

Vor Biopharma currently has 68,398,826 shares outstanding. The market capitalization of Vor Biopharma is $61.37 million. Vor Biopharma has a price to earnings ratio (PE ratio) of -0.50.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Vor Bio to Participate in the Stifel 2024 Healthcare Conference

CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Vor Bio Reports Third Quarter 2024 Financial Results and Provides Company Update

Company to present trem-cel + Mylotarg clinical data update at American Society of Hematology (ASH) 2024 annual meetingHan Choi, M.D., LL.M, seasoned healthcare institutional investor, appointed...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.0215	2.58072260233	0.8331	1.0599	0.81	676013	0.97508456	CS
4	0.1446	20.3661971831	0.71	1.0599	0.6707	598797	0.8415715	CS
12	-0.1454	-14.54	1	1.19	0.6354	1008998	0.86806593	CS
26	-0.8354	-49.4319526627	1.69	1.87	0.6354	642353	0.93793442	CS
52	-1.0754	-55.7202072539	1.93	3.1399	0.6354	451766	1.25249154	CS
156	-17.0854	-95.2363433668	17.94	18.35	0.6354	239670	2.83325019	CS
260	-41.1654	-97.9662065683	42.02	63.62	0.6354	225779	6.78899648	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CEROCERo Therapeutics Holdings Inc	$ 0.2853 (52.40%)	1.17B
CYCNCyclerion Therapeutics Inc	$ 2.5306 (42.97%)	11.99M
SPPLSIMPPLE Ltd	$ 1.2503 (41.60%)	165.69M
PULMPulmatrix Inc	$ 6.5586 (39.54%)	5.37M
ZTEKZentek Ltd	$ 1.2574 (29.96%)	309.67k
TFFPTFF Pharmaceuticals Inc	$ 0.376101 (-76.49%)	9.23M
EYENEyenovia Inc	$ 0.10185 (-70.05%)	51.98M
CTXRCitius Pharmaceuticals Inc	$ 0.1974 (-39.89%)	11.15M
VVPRVivoPower International PLC	$ 0.8151 (-39.62%)	2.3M
IPWiPower Inc	$ 0.7302 (-39.15%)	1.13M
CEROCERo Therapeutics Holdings Inc	$ 0.2853 (52.40%)	1.15B
ELABElevai Labs Inc	$ 0.0211 (-19.47%)	377.69M
NVDANVIDIA Corporation	$ 141.98 (-3.26%)	244.07M
SPPLSIMPPLE Ltd	$ 1.2503 (41.60%)	164.49M
STISolidion Technology Inc	$ 0.44 (25.71%)	139.46M

PonkenPlonken

PonkenPlonken 4 days ago

VINC type move coming

PonkenPlonken

PonkenPlonken 7 days ago

super super undervalued. Sid Mukherjee - gifted founder. Couple with recent clinical validation...
Problem in AML is not the drugs efficacy rather the possibility to handle the drug. They might just fix that.

PonkenPlonken

PonkenPlonken 1 week ago

PonkenPlonken

PonkenPlonken 2 months ago

The buyers of all these shares arent going anywhere. Waiting for it to unfold.
All the traders didnt understand this prudent PR? You dont need fluffy if you have the real deal

PonkenPlonken

PonkenPlonken 2 months ago

remember this was founded to heal patients, not retire the management. This is a mission by the brilliant founder and the $$ will come as a by product of things being very right.

PonkenPlonken

PonkenPlonken 2 months ago

Helps where CAR T cant in AML. Its about giving MORE of the drugs that heal..... they work but the body cant handle them. With VOR, it can.

People might just start realizing how huge the possibilities for this are.... GIVEN: r/r AML makes up 40-50% in younger patients and the great majority of elderly patients.
Now experiment with the 20bn TAM for r/r AML and some funny numbers start popping up.
Look at the founder... hes onto something.

the actual data will speak soon. The investigator is ultra optimistic.... he likely saw more.

glenn1919

glenn1919 2 months ago

VOR................................https://stockcharts.com/h-sc/ui?s=VOR&p=W&b=5&g=0&id=p86431144783

Monksdream

Monksdream 4 months ago

VOR new 52 week low

Monksdream

Monksdream 5 months ago

VOR new 52 week low

PonkenPlonken

PonkenPlonken 5 months ago

Sid Mukherjee saw the potential in Saar Gills and Carl Junes approach and funded VOR==== shielding the right cells and attacking the cancer. For simplicity, it could be summed up as bottom up selectivity.................
Very different from all the other CAR T stuff out there that is pretty much top-down-y. And in my opinion, top down systems dont work.
5am and RA certainly think so. Will go back to the IPO price and then some is my bet.

Monksdream

Monksdream 5 months ago

GNPX new 52 week low

PonkenPlonken

PonkenPlonken 5 months ago

Im starting to think someone just buys them out.
Interesting action yesterday.

Monksdream

Monksdream 5 months ago

VOR new 52 week low

Monksdream

Monksdream 6 months ago

VOR new 52 week low

PonkenPlonken

PonkenPlonken 6 months ago

elevated volume for quite some time now.

PonkenPlonken

PonkenPlonken 7 months ago

https://en.wikipedia.org/wiki/Siddhartha_Mukherjee founder is a smart man. They can do Car T without the tox.

Monksdream

Monksdream 8 months ago

glenn1919

glenn1919 8 months ago

VOR.....................................https://stockcharts.com/h-sc/ui?s=VOR&p=W&b=5&g=0&id=p86431144783

Sabre Resources

Delayed Upgrade Clock